The largest database of trusted experimental protocols

Architect plus c8000

Manufactured by Abbott
Sourced in United States

The Architect Plus C8000 is a fully automated, high-throughput clinical chemistry analyzer developed by Abbott. It is designed to perform a wide range of clinical tests, including but not limited to chemical, immunoassay, and enzyme assays. The Architect Plus C8000 is capable of processing a large volume of samples with high accuracy and efficiency.

Automatically generated - may contain errors

8 protocols using architect plus c8000

1

Serum Biochemical Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood from each animal was collected in a stopper tube (without anticoagulants) and centrifuged: serum samples were then immediately frozen for further biochemical analyses. Abbott specific kits for automated chemistry analyzer (Architect C8000 Plus, Abbott, Sesto San Giovanni (MI) Italy) were used for the evaluation of alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinine, glucose, triglycerides, urea, total cholesterol, high density lipoprotein (HDL), C-reactive protein (PCR), creatine kinase MB (CK–MB) and lactate dehydrogenase (LDH), according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

Cytotoxicity Evaluation via LDH and CK-MB

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue damage was evaluated by measuring two cytotoxic markers, lactate dehydrogenase (LDH) (Abbott Laboratories, Abbott Park, IL, USA, 2P56-21) and creatine kinase MB isozyme (CK-MB) (Abbott, 6K25-30), in blood samples according to the manufacturer's instructions with the aid of a clinical chemistry analyzer (Abbott, Architect C8000 Plus).
+ Open protocol
+ Expand
3

Assessing Ischemic Albumin Biomarker

Check if the same lab product or an alternative is used in the 5 most similar protocols
IMA levels were determined by albumin cobalt binding test, a rapid colorimetric method developed by Bar-Or et al. [16 (link)]. The method is based on the binding ability of reduced cobalt ions (Co2+) of HSA due to ischemia. Briefly, a known amount of exogenous Co (CoCl2) was added to serum samples. Albumin, which is altered as a result of ischemic processes, binds to the Co(II) to a far lesser extent and the excess (unbound) amount of Co2+ forms a colored complex with dithiothreitol, which is measured spectrophotometrically at 480 nm. Plasma albumin levels were measured in a calibrated and well-controlled autoanalyzer using the bromocresol green method (Architect Plus C8000, Abbott, USA).
+ Open protocol
+ Expand
4

Diagnosing Dysglycemia Using OGTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Participants underwent a 75-gram OGTT after an overnight fast at recruitment. Venous fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG) and HbA1c were measured (Abbott Architect Plus c8000, Wiesbaden, Germany). Pre-diabetes is defined as impaired fasting glucose (IFG): FPG 6.1–6.9 mmol/L with 2hPG < 11.1 mmol/L, or impaired glucose tolerance (IGT): FPG < 6.1 mmol/L with 2hPG ≥ 7.8 and <11.1 mmol/L. Diabetes is defined as: FPG ≥ 7.0 mmol/L or 2hPG ≥ 11.1 mmol/L9 . Participants with IFG, IGT or diabetes were collectively grouped as dysglycemia.
+ Open protocol
+ Expand
5

Spectrophotometric Analysis of Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents and chemicals were purchased from Sigma-Aldrich. Spectrophotometric analysis was performed with a Shimadzu UV-1800 spectrophotometer with a temperature-controlled cuvette holder and an automated analyzer (Architect Plus C8000, Abbott, USA).
+ Open protocol
+ Expand
6

Biochemical Indicators Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Biochemical indicators were detected by an automatic biochemical analyzer (Architect Plus C8000, Abbott, USA) in clinical laboratory of our hospital, including triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C).
+ Open protocol
+ Expand
7

Serum IMA Levels in Cerebral Infarction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral venous blood samples were collected from patients and healthy control into tubes with EDTA, immediately after diagnosed for CI. Samples were centrifuged at 3500 rpm/min for 15 min at room temperature. The plasma samples were extracted and frozen below -80°C for use. A Albumin cobalt assay (ACB) was used to determine the serum IMA levels as described in a previous study (13) (link). ACB Assay for IMA was done colorimetrically as follows: 6200 μL of serum was mixed with 50 μl of CoCl2 (1 g/L) vigorously for 10 min, 50 μL of dithiothreitol (DTT) (1.5 g/L) was added and left for 2 min, and 0.9 N NaCl was then added. Plasma albumin levels were measured in a calibrated and well-controlled autoanalyzer using the bromocresol green method (Architect Plus C8000, Abbott, USA). It was read colorimetrically at 470 nm as ABS U/mL (absorbance units). The conditions of patients after treatment were assessed by National Institutes of Health Stroke Scale (NIHSS). The correlation between serum IMA levels at admission and NIHSS after treatment was also analyzed.
+ Open protocol
+ Expand
8

Ischemia-Modified Albumin Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
We measured Ischemia-Modified Albumin (IMA) levels by using cobalt binding test developed by Bar-Or et al. [13] . Briefly, this method is based on the binding of cobalt with dithiothreitol (DTT) and measuring spectrophotometrically at 480 nm by adding a known amount of cobalt into the serum. The results were expressed as absorbance units (ABSU) (Abbot Architect C-8000). Plasma albumin levels were measured in autoanalyzer by using bromecresol green method (Architect Plus, C-8000, Abbott, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!